Ark Therapeutics Group plc (LSE: AKT) ("the "Company") has received notification that on 17 May 2012 Peter Keen, Non-Executive Director, purchased 750,000 ordinary shares of 1 pence each in the Company through his Self Invested Pension Plan at a price of 2.85 pence per share.
As previously announced, Peter Keen retired as a Director with effect from the conclusion of yesterday's Annual General Meeting of the Company.
For further information please contact:
Ark Therapeutics Group plc
Dr Edward Bliss, Company Secretary
+44 (0)20 7388 7722
This information is provided by RNS
The company news service from the London Stock Exchange
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.